@article{6e59cc0b5cab4995806d59c95895eafd,
title = "Benign Prostatic Hyperplasia Treatment On Its Way to Precision Medicine: Dream or Reality?",
author = "Arkadiusz Miernik and Roehrborn, {Claus G.}",
note = "Funding Information: Conflicts of interest: Arkadiusz Miernik receives research funding from the German Federal Ministry of Education and Research and travel support from the European Association of Urology and the German Society of Urology; is a consultant for KLS Martin, Avateramedical, LISA Laser Products, Schoelly Fiber Optics, Dornier MedTech Laser, Medi-Tate, and B. Braun New Ventures; is a speaker for Richard Wolf and Boston Scientific; served as a reviewer for Ludwig Boltzmann Gesellschaft; and has interests in patents WO2014173468A1 (licensed to Purenum), EP2988681A1 (licensed to Purenum) WO2015082372A1 (pending), WO2017207361A1 (pending), DE102019220537A1 (pending), DE102019134352A1 (pending), DE102015003560B3, and WO2021005060A1 (pending). Claus G. Roehrborn receives financial compensation as a consultant for GlaxoSmithKline, Boston Scientific, ProVerum, and ReSurge International, and as an investigator and consultant for Zenflow, Medeon Biodesign, and Teleflex; and participates in an advisory board for Teleflex.",
year = "2022",
month = mar,
doi = "10.1016/j.euf.2022.03.023",
language = "English (US)",
volume = "8",
pages = "363--364",
journal = "European Urology Focus",
issn = "2405-4569",
publisher = "Elsevier BV",
number = "2",
}